Clinical Trial Update: CellCept/Iron Study: The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction in Renal Allograft Recipients

View source ↗

Summary

The completed trial evaluated the interaction between iron ions and mycophenolate mofetil (CellCept) in renal allograft recipients with end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: University of Michigan | Conditions: End Stage Renal Disease | Status: COMPLETED